Biotech developing lower back pain remedy raises $6M

8:55 am by | 1 Comments

back painThe serial entrepreneur who founded and led pediatric drug developer NextWave Pharmaceuticals that Pfizer acquired last year, is now part of a management team interested in developing a treatment for lower back pain. The condition affects about 31 million people in the U.S., according to the American Chiropractic Association.

Mahendra Shah, a venture partner with Vivo Ventures and the executive chairman of Semnur Pharmaceuticals, told MedCity News in a phone interview that the company has raised $6 million as part of a $30 million round to advance its injectable drug for lower back pain. The phase 2 clinical trials for the drug are expected to begin in the third quarter next year. He declined to comment further.

The back pain market is projected to rise to $23 billion by 2018, according to WWMR Inc. The market is dominated by abuse-resistant opioids. A description of the company on its LinkedIn page said it’s developing non-opioid products for underserved patients:

“We believe we have the technology to improve products’ efficacy and safety, and make a critical difference in the treatment of back pain patients.”

Jaisim Shah is the CEO of the company. Among the other board members are Brent Ahrens of Canaan Partners, according to a Form D filing with the U.S. Securities and Exchange Commission.

In the U.S., it plans to either develop and commercialize the product on its own or work with partners, according to its LinkedIn page. Beyond the U.S., it plans to commercialize products through select regional partnerships.

Copyright 2015 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Stephanie Baum

By Stephanie Baum

Stephanie Baum is the East Coast Innovation Reporter for She enjoys covering healthcare startups across health IT, drug development and medical devices and innovations deployed to improve medical care. She graduated from Franklin & Marshall College in Pennsylvania and has worked across radio, print and video. She's written for The Christian Science Monitor, Dow Jones & Co. and United Business Media.
Visit website | More posts by Author

Back Pain
Back Pain

Lower back pain is very common in our society and Preventing back pain is easier than treating it.